Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5670)
All Articles published online
|
Aug 21, 2012 (publication date) through Apr 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hokari A, Ishikawa T, Tajiri H, Matsuda T, Ishii O, Matsumoto N, Okuse C, Takahashi H, Kurihara T, Kawahara KI, Maruyama I, Zeniya M. Efficacy of MK615 for the treatment of patients with liver disorders. World J Gastroenterol 2012; 18(31): 4118-4126 [PMID: 22919243 DOI: 10.3748/wjg.v18.i31.4118] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i31/4118.htm |
| Number | Citing Articles |
| 1 |
Masashi Yanaki, Masayuki Kobayashi, Atsushi Aruga, Minoru Nomura, Makoto Ozaki. In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation. Integrative Cancer Therapies 2018; 17(3): 646 doi: 10.1177/1534735418766403
|
| 2 |
Takashi Hoshino, Hitoshi Takagi, Atsushi Naganuma, Eri Koitabashi, Sanae Uehara, Naomi Sakamoto, Tomohiro Kudo, Ken Sato, Satoru Kakizaki. Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot “<italic>Prunus mume</italic>”. World Journal of Hepatology 2013; 5(10): 596-600 doi: 10.4254/wjh.v5.i10.596
|
| 3 |
Katsuya Hiraishi, Fumie Jimma, Hiroyuki Soma, Tomohiro Kagawa, Ippei Yamaoka. Investigating a novel hepatoprotective substance from ume extract (heated Japanese apricot juice concentrate). Part 2: Elucidation of chemical structure. NFS Journal 2022; 26: 33 doi: 10.1016/j.nfs.2021.05.002
|
| 4 |
Katsuya Hiraishi, Fumie Jimma, Hiroyuki Soma, Tomohiro Kagawa, Ippei Yamaoka. Investigating a novel hepatoprotective substance from ume extract (heated Japanese apricot juice concentrate). Part 1: Finding an active substance using a liver injury rat model. NFS Journal 2022; 26: 22 doi: 10.1016/j.nfs.2021.05.003
|
| 5 |
Jianxing Luo, Yang Zhang, Xiaoyu Hu, Sen Zhong, Guo Chen, Yanyan Wang, Wu Lin, Cheng Yi, Hong Zhu. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by d-galactosamine in rats. Journal of Ethnopharmacology 2015; 161: 53 doi: 10.1016/j.jep.2014.12.003
|
| 6 |
Alberto Beretta, Roberto Accinni, Cinzia Dellanoce, Annamaria Tonini, Jean-Michel Cardot, Anthony Bussière. Efficacy of a Standardized Extract ofPrunus mumein Liver Protection and Redox Homeostasis: A Randomized, Double-Blind, Placebo-Controlled Study. Phytotherapy Research 2016; 30(6): 949 doi: 10.1002/ptr.5597
|
| 7 |
Şule Nur Dikilitaş Saçkesen, Sibel Karakaya, Gökhan Durmaz, Orhan Gündüz, Didem Şahingil, Ali Adnan Hayaloğlu. Unveiling the Potential of EU PDO Registered Malatya Apricot (Prunus armeniaca L.): Compositional, Functional, Nutritional, and Economic Aspects. ACS Food Science & Technology 2025; 5(3): 909 doi: 10.1021/acsfoodscitech.4c00979
|
| 8 |
Hye-jin Yoon, Bong Soo Cha. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World Journal of Hepatology 2014; 6(11): 800-811 doi: 10.4254/wjh.v6.i11.800
|
| 9 |
Eleftheria C. Sagiadinou, Eleni A. Karavia, Eva Xepapadaki, Evangelia Zvintzou, Aikaterini Hatziri, Dimitra-Sotiria Karampela, Panagiota C. Giannopoulou, Dionysios J. Papachristou, George Panayiotakopoulos, Kyriakos E. Kypreos. Benefits of a fixed-dose combination of standardized P. mume extract with choline on adipose tissue mitochondrial metabolic activity and pancreatic β-islet secretory capacity in mice. Phytomedicine Plus 2022; 2(3): 100317 doi: 10.1016/j.phyplu.2022.100317
|
| 10 |
Christian Bailly. Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot). Journal of Ethnopharmacology 2020; 246: 112215 doi: 10.1016/j.jep.2019.112215
|
| 11 |
Nazish Butt, Muhammad Masood, Aamir Ali. Efficacy and Safety of Prunus mume and Choline in Patients with Nonalcoholic Fatty Liver Disease. Euroasian journal of hepato-gastroenterology 2023; 13(2): 124 doi: 10.5005/jp-journals-10018-1397
|
| 12 |
Ming Hong, Sha Li, Hor Tan, Ning Wang, Sai-Wah Tsao, Yibin Feng. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects. International Journal of Molecular Sciences 2015; 16(12): 28705 doi: 10.3390/ijms161226126
|
| 13 |
Qiao Liu, Danni Chen, Huixin Liu, Miaomiao Wang, Yaqian Zhou, Hui Dai, Jian Liu, Wu Yin, Fangzhou Yin. Characterization of Quality Marker for Mume Fructus Pulp by Ultra‐Performance Liquid Chromatography‐Quadrupole Time‐of‐Flight Mass Spectrometry‐Based Untargeted Metabolomics Combined With Biological Activities. Phytochemical Analysis 2025; doi: 10.1002/pca.3502
|
| 14 |
Juan Zheng, Ting Chen, Xin Guo, James M. Ntambi, Chaodong Wu. Lipid Signaling and Metabolism. 2020; : 273 doi: 10.1016/B978-0-12-819404-1.00014-2
|
| 15 |
Xue-Peng Gong, Ying Tang, Yuan-Yuan Song, Guang Du, Juan Li. Comprehensive Review of Phytochemical Constituents, Pharmacological Properties, and Clinical Applications of Prunus mume. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.679378
|